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Abstract 
 The time required to initiate clinical trials, from 
declaration of the investigator’s intent to opening of 
the study for participant accrual, is cited as often 
being so long that clinical research is seriously 
impeded.  Efforts to improve operational efficiency of 
trial initiation are confounded by the work flow 
complexity and the variations encountered with 
different types of trials and institutional 
environments.  A computer Protocol Lifecycle 
Tracking (PLT) tool would enable study initiation 
staff to manage the process, and the various clinical 
research stakeholders to monitor the progress of a 
study’s initiation, as well as obtain data on the work 
flow to identify those activities  that are in need of 
operational efficiency improvement.   The objective 
of our work was to develop use cases and system 
requirements for a PLT tool.  The result of our study 
is a use case document that can serve as the 
specifications for developing  a PLT application.  
Introduction 
A 2005 report on restructuring the cancer clinical 
trials enterprise stipulated the reduction of 
operational barriers to trial initiation among its 
primary goals.1 Supporting the significance of trial 
initiation delay, Dilts and his colleagues, who have 
uniquely studied these processes involved in opening 
trials, concluded that in some situations “The steps 
required to develop and activate a clinical trial may 
require as much or more time than the actual 
completion of a trial.”2  Another Dilts study, which  
evaluated the trial initiation processes at a major 
academic medical center, noted that while 
administrative barriers to opening trials is often 
criticized by researchers, the process has in general 
not been formally documented or evaluated.3   
The sometimes long delays in activating clinical 
trials, as well as the conflicting anecdotal attributions 
for these delays, are well known to those involved in 
clinical trials research.  Correspondingly, 
comprehensive means for monitoring the work flow 
of study initiation by the various stakeholders – 
principal investigators, clinical research associates, 
administrators – are not available. To address this, we 
have undertaken the development of use cases and 
system requirements for a computer Protocol 
Lifecycle Tracking tool, which would not only 
provide the capability to  manage the process flow 
and monitor the progress of trial initiation in real 
time, but also deconstruct the complex work flow and 
provide institution and study-type specific data on the 
contributing factors to initiation delays. 
Background 
The National Cancer Institute’s cancer Biomedical 
Informatics Grid (caBIG®) program, begun in 2004, 
includes clinical trials research informatics among its 
primary domains for investigation.  The caBIG® 
Clinical Trials Management System (CTMS) work 
space has created a Business Architecture Model 
(BAM) of the clinical trials research work flow, from 
study initiation, through study conduct, to study 
closure.4 The BAM describes the activities, goals, 
people, and organizational needs involved in clinical 
trials.  The almost 400 pages of use cases developed 
for the BAM informed CTMS participants of the 
variability and complexity of  the clinical trials work 
flow:  the activities involved in planning, initiating, 
and conducting trials varies according to the sponsor 
(industry, government agency, cooperative group, or 
institutional investigator initiated) and whether the 
sponsor (e.g., cooperative group) or performance site 
(e.g., cancer center) perspective is being considered;  
whether the trial is interventional or non-
interventional; and the specifics of the trial itself 
(e.g., pharmaceuticals or device involved?).   
With this comprehensive BAM to draw upon, we 
decided to develop the use cases and requirements for 
a Protocol Lifecycle Tracking computer tool that 
could accommodate the inherently variable work 
flow of initiating clinical trials research.  So while the 
caBIG® BAM describes the clinical trial processes, 
this PLT use case project describes the requirements 
for a tool which can manage these processes.  
Furthermore, while this study arose from the caBIG® 
program, non-oncology clinical trials expertise was 
also included for these specifications, to minimize 
disease-specific applicability. 
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Methods 
The objective of this study was to define the 
functional requirements for a Protocol Lifecycle 
Tracking (PLT) tool.  While the activities of the trial 
initiation phase was the focus for this requirement 
gathering, it is felt that the tool capabilities for this 
lifecycle phase will probably satisfy the needs of the 
subsequent trial conduct and closure phases, although 
this cannot be said with certainty until these later 
phases are further evaluated.  But for this study, the 
conduct and closure phases were out of scope. 
To gather the functional requirements for the PLT 
tool we employed use case systems engineering 
methodology.5  The use cases describe the system 
processes and actors involved in the use of the PLT 
tool.  It should be noted that the use cases are for the 
PLT tool – not for the clinical trial initiation work 
flow that is being monitored by the PLT tool.  Thus 
the actors consist of clinical trial study personnel who 
use the PLT tool, including coordinators, managers, 
and PLT system administrators. 
Use cases can vary in the degree of detail they 
capture.  Also the structural form of a use case can 
vary, but certain elements are always included.   
These basic use case elements are a name, brief 
description of the use case’s purpose, a summary, or 
“storyboard,” giving an overview, a list of actors 
involved, the pre-condition describing the system 
state required for the use case’s deployment, the flow 
of events, and the post-condition describing the 
system state after the completion of the use case. 
Use cases stipulate what a system must do, but not 
how it is to be done.  Software development teams 
can use the use cases to define the end user 
functionality of the system they are coding, but they 
are free to employ whatever methods they choose to 
implement that functionality.  For example, the 
choice between employing thick or thin clients for an 
application would not be directed by the use cases.  
However a gray area in this distinction between 
“what” as opposed to “how” is the degree of user 
interface detail that should be included (if any) in use 
case definitions.  End users are more directly affected 
by an application’s “user friendliness” than, for 
instance, the choice of database deployment.  For our 
work with setting user functionality for the PLT tool 
we included user interface wireframes for this tool, as 
a “picture” that expresses a thousand words in 
conveying the final overall functionality we want to 
obtain. 
Results 
Overview of the PLT tool 
The Protocol Lifecycle Tracking (PLT) tool is 
envisioned to be a standalone application that can be 
adopted by researchers to assist in the evolution of a 
protocol. The PLT will provide a view of data from 
disparate sources and will function as a dashboard to 
access real-time data on demand for those with the 
appropriate access privileges. By using PLT, the 
following innovative advantages could be realized: 
• Ability to manage the process flow to achieve 
compliance with associated timelines 
• Documentation of the lifecycle of a protocol 
over its course. 
• Ability to query status of protocol in real time. 
• Visualization of the clinical trial process map for 
a specific site. 
• Identify bottlenecks and/or redundant steps in the 
process. 
• Allow for a comparison of the clinical trial 
process between sites and sponsors. 
• Transparency of the clinical trial process 
between sites and sponsors. 
• Enable access to metrics to evaluate 
performance. 
• Enable automatic notifications and alerts to 
communicate completion status of essential 
milestones in the clinical trials process. 
 
The foundation of the PLT tool is a library populated 
with generic templates of  work flow Activities and 
Table 1. PLT tool terminology. 
Workflow 
Template 
A Workflow Template is a user defined plan with one or more activities that serve as the basis for creating a Study 
Workflow.  Templates serve as the starting point for creating a study-specific workflow which is applied to an actual 
clinical trial.  Multiple templates can be created to account for variances between different types of trials. 
Activity An activity is a logical grouping of milestones that define a measurable amount of work or specific function.  For PLT 
purposes, an activity can contain any number of milestones, including no milestones.  In cases where an activity contains 
no milestones, the activity is in effect a milestone, but for the sake of consistency will still be defined as an activity.  
Activities are the building blocks for a Workflow Template. Only activities can be added to a template. 
Milestone A milestone is an event that indicates the completion of a major deliverable.  Milestones are measurable and serve as 
progress markers, but by definition, are independent of time (meaning they have no duration), therefore no work or 
consumption of resources is associated with them.  Milestones are sub-events within an activity and must be associated 
with an activity. 
Dependency A dependency is a relationship between activities or milestones.  Dependencies include activities/milestones that cannot be 
started until a previous activity/milestone has completed and/or a pre-defined amount of time has elapsed since the 
completion of an activity/milestone. 
Workflow 
Template 
Library 
The Workflow Template Library is the collection of all of the defined Workflow Templates as well as the defined 
Activities that can be associated with a Workflow Template. 
Study 
Workflow 
A study workflow is a template that has been applied to a specific actual study.  Once a template has been applied to a 
study, the Study Workflow becomes an independent entity distinct from the original template.  The Study Workflow can 
be modified to suit the particular study to which is was assigned; however, these changes will not reflect back on the 
original Workflow Template. 
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associated Milestones (see Table 1). For example, the 
activity “IRB Approval” may have as associated 
milestones “Protocol Submitted,” “Protocol 
Reviewed,” “Protocol Conditionally Accepted,” and 
“Protocol Approved.”  Each template can have 
expected normal time intervals for reaching these 
milestones assigned so that the progress of a trial’s 
activities can be flagged as proceeding normally or as 
being delayed.  Activities and milestones can occur 
iteratively (as iterative IRB submissions with 
modifications), and they can occur concurrently with 
other activities or be dependent upon the successful 
completion of another activity.  
These generic templates can be created with PLT for 
typical studies of different types (e.g., interventional 
cooperative group drug study) and for different 
perspectives (coordinating center vs. participating 
site).  These templates can then be modified as 
needed for application to managing the process flow 
and tracking the progress of a specific study. 
PLT tool Use Cases 
A total of 63 use cases were defined and documented 
for the PLT tool and are publicly available.6  The 
actors and use case names are summarized in Table 
2. 
Table 2.  Summary of PLT tool actors and use cases.       
Actors: 
  
  
  
 Select Workflow Template  
 system administrator 
  
  
  
 Apply Workflow Template to Study  
 coordinating center administrator 
 
  
  
 Modify Study Plan  
  participating site administrator 
 
  
  
 Set Triggered Alerts  
  clinical trials manager 
  
  
  
 Verify and Approve Study Plan  
 coordinator 
  
  
 
Modify Study Plan  
  study team (e.g., data manager, protocol nurse)   
 
  Select Study Plan  
  Principal Investigator 
  
  
 
  Modify Study Plan  
     
  
  
 
  Modify Triggered Alerts  
 Use Cases: 
  
  
 
  Verify and Approve Study Plan  
 Manage Workflow Library 
  
  
 
 Stop Study Plan  
   Manage Activities  
  
  
 
 Select Study Plan  
    Add New Activity  
  
  
 
  Stop Study Plan  
     Create a New Activity  
 
  
 
  Re-start Study Plan  
     Set Default Activity Attributes  
 
  
 
 Import/Export Study Plans  
     Add/Modify Activity Milestone(s)  
 
   Manage Study Plan 
      Set Default Milestone Attributes  
 
  
 
 Update Study Plan  
     Set Default Milestone Dependencies       Select Study Plan  
     Verify and Approve Activity  
 
     Select Activity and Milestone  
   Retire Activity  
  
     Update Milestone Progress  
    Select Activity  
  
     Save Study Plan  
     Retire Activity  
  
    View Study Plan  
     Import/Export Activity Libraries  
 
    Select Study Plan  
  Manage Workflow Templates  
 
     View Study Plan  
     Add New Workflow Template  
 
    Subscribe to Triggered Alerts  
     Create a New Workflow Template  
 
     Select Study Plan  
     Add/Remove Activities from Workflow Template       Select Activity/Milestone  
     Add/Remove Milestones from Workflow Template      Subscribe to Activity/Milestone  
    Add Dependencies to Workflow Template       View Dashboard  
     Verify and Approve Workflow Template     Manage Portfolio  
     Retire Workflow Template  
 
    View Metrics  
     Select Workflow Template  
 
     View Reports  
     Retire Workflow Template  
 
   Administer System   
    Import/Export Workflow Template  
 
    Manage User Access  
 Manage Study Plan Library 
  
   
 
 Manage Study Roles  
   Create Study Plan  
  
   
 
 Manage Email Templates  
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Discussion 
The complexity of protocol activities and milestones 
– that they may occur iteratively, or that they may 
occur concurrently or be dependent on successful 
completion of another, or that their occurrence at all 
depends on the trial’s sponsor – is managed primarily 
in the use cases “set default milestone attributes” and 
“set default milestone dependencies” as well as in the 
tool’s overall ability to have different templates and 
study plans for different protocols (e.g., cooperative 
group drug studies vs. investigator initiated non-
interventional trial).  The need for this flexibility is 
apparent if one considers a typical protocol initiation 
work flow as summarized in Figure 1. This schematic 
focusing on study initiation shows the different paths 
and activities necessitated for pharmaceutical 
industry trials, and the iterative nature of some 
processes.  It should be kept in mind that this work 
flow is from the perspective of a participating site – a 
coordinating site would have a different work flow 
for activating the same protocol. 
A very significant benefit of using this tool will be 
the ability to manage the process workflow so that 
the clinical research staff know what activities are 
required, and when they are to be performed.  
Furthermore, delays in the anticipated schedule can 
be detected quickly and interventions undertaken to 
prevent a trial initiation from becoming “stuck.” 
As mentioned above, non-cancer clinical trial work 
flows were also considered.  While work flow details 
may differ, no disease-specific PLT requirements 
were encountered. 
As had been stated in the Methods section, use case 
analysis is focused on the “what” rather than the 
“how.”  While user interface specification in a sense 
crosses this boundary, several wireframes were 
prepared for our study of PLT tool use cases to 
convey the overall “look and feel” being sought.  A 
wireframe of a possible dashboard for a clinical trials 
manager, showing a summary of the status of all trial 
either “in the pipeline” or currently open is shown in 
Figure 2.  Using colors such as green and red for the 
circles in the two columns after each milestone listing 
would immediately convey whether the milestone 
had exceeded its anticipated completion time or not.   
Conclusion 
These use cases have been made available to the 
public as noted in the Reference section.  They have 
also been presented to the caBIG® CTMS work space 
community and discussed at its meetings.  The next 
step will be for  software developers to write code for 
an application that satisfies these use cases. 
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Figure 1. Typical work flow requiring PLT tool representation. 
Figure 2.  Dashboard wireframe for a trials manager showing the status of various protocols. 
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